Pooled Data Analysis of the Long-Term Treatment Effects of Tolvaptan in ADPKD

INTRODUCTION: In 1- and 3-year randomized trials, tolvaptan slowed kidney function decline in subjects with autosomal dominant polycystic kidney disease (ADPKD) at risk of rapid progression. The 3-year trial also evaluated effects on total kidney volume (TKV); slowing of TKV growth was demonstrated....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaolei, Davenport, Eric, Ouyang, John, Hoke, Molly E., Garbinsky, Diana, Agarwal, Indra, Krasa, Holly B., Oberdhan, Dorothee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091612/
https://www.ncbi.nlm.nih.gov/pubmed/35570988
http://dx.doi.org/10.1016/j.ekir.2022.02.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091612/
https://www.ncbi.nlm.nih.gov/pubmed/35570988
http://dx.doi.org/10.1016/j.ekir.2022.02.009

Ejemplares similares